Listen to audio brief:

On April 15, 2025, President Donald J. Trump announced an Executive Order aimed at reducing prescription drug prices for American patients. This Order enhances Medicare’s drug pricing negotiation program, potentially achieving greater savings for seniors and providing substantial discounts for low-income individuals on essential medications. The initiative seeks to increase competition and transparency in the prescription drug market while addressing the roles of intermediaries in drug pricing.

Original: article